Pharmaceutical Drug: Developing a Realistic Project Plan and Budget for You and Your Investors
Developing a drug or biologic can become more expensive and time-consuming than expected. Often, companies struggle with the regulatory pathways for a drug or biologic because of the ambiguity and complexity of the process, coupled with the preclinical, GMP manufacturing, and clinical testing requirements. Additionally, many companies fail to understand the needs of investors and strategic partners.
This session will cover:
· Understanding what goes into a drug or biologic budget and what it costs
· Developing a realistic and successful project plan
· Planning and budgeting for contingencies
Find out more and register.